RhumbLine Advisers’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$490K Sell
201,027
-1,979
-1% -$3.97K ﹤0.01% 2624
2025
Q4
$278K Sell
203,006
-7,720
-4% -$10.2K ﹤0.01% 3015
2025
Q3
$261K Buy
210,726
+1,390
+0.7% +$1.66K ﹤0.01% 3084
2025
Q2
$237K Buy
209,336
+25,628
+14% +$34.1K ﹤0.01% 3136
2025
Q1
$268K Sell
183,708
-8,006
-4% -$15.1K ﹤0.01% 2954
2024
Q4
$408K Buy
191,714
+17,527
+10% +$43.2K ﹤0.01% 2795
2024
Q3
$488K Buy
174,187
+9,679
+6% +$25.8K ﹤0.01% 2711
2024
Q2
$383K Buy
164,508
+12,473
+8% +$36.8K ﹤0.01% 2849
2024
Q1
$680K Buy
152,035
+6,074
+4% +$25.3K ﹤0.01% 2476
2023
Q4
$469K Buy
145,961
+6,816
+5% +$19.3K ﹤0.01% 2695
2023
Q3
$441K Sell
139,145
-5,096
-4% -$22.3K ﹤0.01% 2681
2023
Q2
$717K Buy
144,241
+15,009
+12% +$81.2K ﹤0.01% 2472
2023
Q1
$638K Buy
129,232
+3,730
+3% +$23.9K ﹤0.01% 2323
2022
Q4
$789K Sell
125,502
-3,371
-3% -$31.2K ﹤0.01% 2256
2022
Q3
$1.39M Buy
128,873
+10,174
+9% +$138K ﹤0.01% 1966
2022
Q2
$1.35M Buy
118,699
+34,281
+41% +$304K ﹤0.01% 1981
2022
Q1
$769K Sell
84,418
-5,503
-6% -$57.3K ﹤0.01% 2238
2021
Q4
$1.34M Sell
89,921
-847
-0.9% -$14.9K ﹤0.01% 2082
2021
Q3
$2.33M Buy
90,768
+2,938
+3% +$69.8K ﹤0.01% 1816
2021
Q2
$2.29M Buy
87,830
+26,468
+43% +$755K ﹤0.01% 1887
2021
Q1
$2.17M Sell
61,362
-6,034
-9% -$204K ﹤0.01% 1870
2020
Q4
$1.7M Buy
67,396
+3,232
+5% +$105K ﹤0.01% 1923
2020
Q3
$2.42M Sell
64,164
-11,826
-16% -$446K ﹤0.01% 1563
2020
Q2
$3.25M Buy
75,990
+21,406
+39% +$774K 0.01% 1450
2020
Q1
$1.06M Buy
54,584
+1,360
+3% +$32.4K ﹤0.01% 1855
2019
Q4
$1.38M Buy
53,224
+1,814
+4% +$50K ﹤0.01% 1945
2019
Q3
$1.4M Buy
51,410
+118
+0.2% +$3.36K ﹤0.01% 1892
2019
Q2
$1.38M Buy
51,292
+19,944
+64% +$556K ﹤0.01% 1920
2019
Q1
$906K Buy
31,348
+560
+2% +$16.2K ﹤0.01% 2087
2018
Q4
$829K Buy
+30,788
New +$818K ﹤0.01% 2088

Other funds holding ALLO